Matches in SemOpenAlex for { <https://semopenalex.org/work/W2797362009> ?p ?o ?g. }
- W2797362009 endingPage "357" @default.
- W2797362009 startingPage "351" @default.
- W2797362009 abstract "Sensitive and specific biomarkers of Pancreatic Ductal Adenocarcinoma (PDAC) are desperately needed to allow early diagnosis and improve patient's survival. Ezrin autoantibodies were recently described as present in 93% of PDAC patients and 40% of healthy subjects who later developed PDAC. However, another prospective study failed to replicate these findings. Both studies were based on the use of a solid phase ELISA immunoassay.We aimed at re-evaluating the usefulness of Ezrin autoantibodies as PDAC biomarkers using the Luciferase Immuno Precipitation System (LIPS), an alternative immunoassay format that found successful application for the measurement of autoantibodies against pancreatic autoantigens.We produced a Nanoluciferase™ tagged Ezrin (NLuc-Ezrin). NLuc-Ezrin was then used as antigen in LIPS to test for Ezrin autoantibodies patients affected by PDAC (n= 40), other pancreatic diseases (OPD, n= 50), and healthy controls (n= 60).Overall, binding in liquid phase to Ezrin by serum antibodies was rare and low titer. Furthermore, we did not find statistically significant differences in the prevalence of Ezrin autoantibodies between patients affected by either PDAC or OPD compared to control.Our results do not confirm the usefulness of Ezrin autoAbs as biomarker of PDAC." @default.
- W2797362009 created "2018-04-24" @default.
- W2797362009 creator A5005129014 @default.
- W2797362009 creator A5033134171 @default.
- W2797362009 creator A5038760660 @default.
- W2797362009 creator A5038867918 @default.
- W2797362009 creator A5057380925 @default.
- W2797362009 creator A5058744766 @default.
- W2797362009 creator A5060976896 @default.
- W2797362009 creator A5073667256 @default.
- W2797362009 creator A5073819372 @default.
- W2797362009 creator A5085032737 @default.
- W2797362009 date "2018-05-29" @default.
- W2797362009 modified "2023-10-18" @default.
- W2797362009 title "No evidence of pancreatic ductal adenocarcinoma specific autoantibodies to Ezrin in a liquid phase LIPS immunoassay" @default.
- W2797362009 cites W1725516260 @default.
- W2797362009 cites W1767516330 @default.
- W2797362009 cites W1966696983 @default.
- W2797362009 cites W1973053017 @default.
- W2797362009 cites W1973484722 @default.
- W2797362009 cites W1975035884 @default.
- W2797362009 cites W1978623733 @default.
- W2797362009 cites W1992856023 @default.
- W2797362009 cites W1996371529 @default.
- W2797362009 cites W2001265129 @default.
- W2797362009 cites W2002888621 @default.
- W2797362009 cites W2004608981 @default.
- W2797362009 cites W2006514238 @default.
- W2797362009 cites W2022742998 @default.
- W2797362009 cites W2026105846 @default.
- W2797362009 cites W2026252313 @default.
- W2797362009 cites W2028687955 @default.
- W2797362009 cites W2031719425 @default.
- W2797362009 cites W2036976019 @default.
- W2797362009 cites W2048977435 @default.
- W2797362009 cites W2070026322 @default.
- W2797362009 cites W2071926149 @default.
- W2797362009 cites W2081943572 @default.
- W2797362009 cites W2099917041 @default.
- W2797362009 cites W2100963793 @default.
- W2797362009 cites W2101659599 @default.
- W2797362009 cites W2107780185 @default.
- W2797362009 cites W2110918404 @default.
- W2797362009 cites W2112843406 @default.
- W2797362009 cites W2113093880 @default.
- W2797362009 cites W2122655209 @default.
- W2797362009 cites W2126237934 @default.
- W2797362009 cites W2131484205 @default.
- W2797362009 cites W2133850008 @default.
- W2797362009 cites W2140234717 @default.
- W2797362009 cites W2146140154 @default.
- W2797362009 cites W2151447617 @default.
- W2797362009 cites W2159227683 @default.
- W2797362009 cites W2162102335 @default.
- W2797362009 cites W2172080880 @default.
- W2797362009 cites W2293565227 @default.
- W2797362009 cites W2296468523 @default.
- W2797362009 cites W2305057039 @default.
- W2797362009 cites W2340056068 @default.
- W2797362009 cites W2346919642 @default.
- W2797362009 cites W2518808027 @default.
- W2797362009 cites W2604084641 @default.
- W2797362009 cites W2736807928 @default.
- W2797362009 cites W2781495850 @default.
- W2797362009 cites W2803908530 @default.
- W2797362009 cites W3022314034 @default.
- W2797362009 cites W4229835970 @default.
- W2797362009 cites W4244578979 @default.
- W2797362009 cites W4249233937 @default.
- W2797362009 cites W4292528167 @default.
- W2797362009 doi "https://doi.org/10.3233/cbm-181218" @default.
- W2797362009 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29660901" @default.
- W2797362009 hasPublicationYear "2018" @default.
- W2797362009 type Work @default.
- W2797362009 sameAs 2797362009 @default.
- W2797362009 citedByCount "1" @default.
- W2797362009 countsByYear W27973620092023 @default.
- W2797362009 crossrefType "journal-article" @default.
- W2797362009 hasAuthorship W2797362009A5005129014 @default.
- W2797362009 hasAuthorship W2797362009A5033134171 @default.
- W2797362009 hasAuthorship W2797362009A5038760660 @default.
- W2797362009 hasAuthorship W2797362009A5038867918 @default.
- W2797362009 hasAuthorship W2797362009A5057380925 @default.
- W2797362009 hasAuthorship W2797362009A5058744766 @default.
- W2797362009 hasAuthorship W2797362009A5060976896 @default.
- W2797362009 hasAuthorship W2797362009A5073667256 @default.
- W2797362009 hasAuthorship W2797362009A5073819372 @default.
- W2797362009 hasAuthorship W2797362009A5085032737 @default.
- W2797362009 hasConcept C121608353 @default.
- W2797362009 hasConcept C126322002 @default.
- W2797362009 hasConcept C142669718 @default.
- W2797362009 hasConcept C147483822 @default.
- W2797362009 hasConcept C1491633281 @default.
- W2797362009 hasConcept C159654299 @default.
- W2797362009 hasConcept C163764329 @default.
- W2797362009 hasConcept C203014093 @default.
- W2797362009 hasConcept C2780210213 @default.
- W2797362009 hasConcept C2780246058 @default.